EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Extended Wearable ECG Monitoring Detects Unrecognised Arrhythmias After COPD Exacerbation: The PRECURSOR Pilot Study

Erweitertes tragbares EKG-Monitoring erkennt nicht erkannte Arrhythmien nach COPD-Exazerbation: PRECURSOR-Pilotstudie

Ourania S Kotsiou iD, Eudoxia Gogou, Dimitra Siachpazidou, Maria Pinaka, Fotini Bardaka, Antonios Garyfallos, Dimitrios Mantzaris iD, Alexandros Garyfallos, Athanasios Konstantinidis iD, Konstantinos I Gourgoulianis iD

The Clinical Respiratory Journal · 2026-11 · 20 (11)

DOI: 10.1111/crj.70240 ↗

Auf einen Blick

Bei 18 nach COPD-Exazerbation hospitalisierten Erwachsenen wurden unter 21 Tagen tragbarem EKG-Monitoring bei 9 Personen zuvor unerkannte klinisch relevante Arrhythmien gefunden.

Fragestellung

Wie häufig werden bei Erwachsenen nach stationär behandelter COPD-Exazerbation mit längerem tragbarem EKG-Monitoring zuvor unerkannte Arrhythmien entdeckt?

Methode

Prospektive, einarmige, ein-zentrische Beobachtungs-Pilotstudie; 21 Tage kontinuierliches Remote-Monitoring mit dreikanaligem ZENSOR-Wearable; Analyse mit exakten 95%-Binomial-Konfidenzintervallen.

Ergebnisse

9/18 Teilnehmende hatten zuvor unerkannte, kardiologisch bestätigte Arrhythmien mit therapeutischer Relevanz (50,0 %; 95 %-KI 26,0–74,0). 16/18 waren mit dem Monitoring zufrieden (88,9 %; 95 %-KI 65,3–98,6).

Einschränkungen

Kleine Pilotstudie ohne Kontrollgruppe; die Autor:innen nennen als Unsicherheit den Einfluss längeren Monitorings gegenüber biologischer Vulnerabilität.

Schlussfolgerung der Autor:innen

Erweitertes tragbares EKG-Monitoring zeigte in der frühen Erholungsphase nach COPD-Exazerbation eine hohe Detektionsrate zuvor unerkannter Arrhythmien. Größere kontrollierte Studien sind erforderlich.

Kernaussagen

  • 9/18 mit zuvor unerkannter, klinisch relevanter Arrhythmie
  • 50,0 % Detektionsrate; 95 %-KI 26,0–74,0
  • 16/18 berichteten Zufriedenheit mit dem Monitoring

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 02.11.2026. Verfasst von Ourania S Kotsiou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, University General Hospital of Larissa, University of Thessaly, Larissa, Greece. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Arrhythmias, Cardiac, Wearable Electronic Devices, Electrocardiography, Ambulatory. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Account of Research Grants of the University of Thessaly.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The period after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease (COPD) is associated with cardiovascular vulnerability. Clinically important rhythm disturbances may be intermittent or asymptomatic and escape routine postdischarge assessment; however, the diagnostic yield of prolonged monitoring is intrinsically influenced by monitoring duration.

Methods

In this prospective, single‐centre observational pilot, 18 adults recently hospitalised for COPD exacerbation underwent continuous remote monitoring for 21 days between September 2019 and February 2020. The three‐lead ZENSOR wearable recorded electrocardiographic rhythm, heart rate and respiratory rate and transmitted full‐disclosure data and predefined alerts for clinician review. The primary outcome was participant‐level detection of previously unrecognised, cardiologist‐confirmed arrhythmias warranting therapeutic evaluation or intervention. Outcomes were analysed descriptively with exact 95% binomial confidence intervals.

Results

Participants were predominantly male (15/18; 83.3%), with a mean age of 73 ± 6 years. Seven had GOLD grade 3–4 airflow limitation, seven received long‐term oxygen therapy, five had coronary artery disease and four had chronic atrial fibrillation. During the planned 21‐day monitoring period, previously unrecognized clinically actionable arrhythmias were detected in 9/18 participants (50.0%; 95% CI: 26.0–74.0). Nonmutually exclusive findings included trigeminy (2/18), third‐degree atrioventricular block (2/18), bradycardia (5/18), newly detected atrial fibrillation (1/18), supraventricular tachycardia (2/18) and nocturnal atrial or ventricular ectopy (8/18). Sixteen participants (88.9%; 95% CI: 65.3–98.6) reported satisfaction with monitoring.

Conclusions

Extended wearable electrocardiographic monitoring produced a high participant‐level detection yield of previously unrecognised arrhythmias during early recovery from hospitalised COPD exacerbation. This finding supports targeted postdischarge rhythm surveillance but does not distinguish biological post‐exacerbation vulnerability from the greater ascertainment achieved by prolonged monitoring. Confirmation requires larger controlled studies with comprehensive cardiopulmonary phenotyping, standardised monitoring‐performance metrics and comparative clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveArrhythmias, CardiacWearable Electronic DevicesElectrocardiography, AmbulatoryElectrocardiographyHumansPilot ProjectsAgedMaleProspective StudiesFemaleRemote Patient MonitoringHeart RateDisease ProgressionHospitalizationDigital HealthAged, 80 and over

Stichwörter der Autor:innen

COPD exacerbationambulatory electrocardiographyarrhythmiacardiovascular riskremote patient monitoringwearable device

Autor:innen und Institutionen

  • Department of Respiratory Medicine, University General Hospital of Larissa, University of Thessaly, Larissa, Greece.
  • Department of Physiology, Faculty of Medicine, University of Thessaly, Larissa, Greece.
  • MOKAAL Information Technology Company, Ioannina, Greece.
  • Department of Nursing, University of Thessaly, Larissa, Greece.
  • Department of Respiratory Medicine, University Hospital of Ioannina, University of Ioannina, Ioannina, Greece.

ORCID-Profile: Ourania S Kotsiou, Dimitrios Mantzaris, Athanasios Konstantinidis, Konstantinos I Gourgoulianis

Förderung

  • Special Account of Research Grants of the University of Thessaly

Zitieren

APA

Kotsiou, O. S., Gogou, E., Siachpazidou, D., Pinaka, M., Bardaka, F., Garyfallos, A., Mantzaris, D., Garyfallos, A., Konstantinidis, A., & Gourgoulianis, K. I. (2026). Extended Wearable ECG Monitoring Detects Unrecognised Arrhythmias After COPD Exacerbation: The PRECURSOR Pilot Study. The Clinical Respiratory Journal, 20(11). https://doi.org/10.1111/crj.70240

Vancouver

Kotsiou OS, Gogou E, Siachpazidou D, Pinaka M, Bardaka F, Garyfallos A, et al. Extended Wearable ECG Monitoring Detects Unrecognised Arrhythmias After COPD Exacerbation: The PRECURSOR Pilot Study. The Clinical Respiratory Journal. 2026;20(11). doi:10.1111/crj.70240

BibTeX
@article{Kotsiou2026,
  author = {Kotsiou, Ourania S and Gogou, Eudoxia and Siachpazidou, Dimitra and Pinaka, Maria and Bardaka, Fotini and Garyfallos, Antonios and Mantzaris, Dimitrios and Garyfallos, Alexandros and Konstantinidis, Athanasios and Gourgoulianis, Konstantinos I},
  title = {Extended Wearable ECG Monitoring Detects Unrecognised Arrhythmias After COPD Exacerbation: The PRECURSOR Pilot Study},
  journal = {The Clinical Respiratory Journal},
  year = {2026},
  volume = {20},
  number = {11},
  doi = {10.1111/crj.70240}
}
Kostenlos starten →